Photo by Vladimir Vladimirov Getty Images
A new Oregon study should raise concerns about the prevalence of transitioning minors.
For years, we were told not to worry about pediatric gender medicine because it was vanishingly rare. Puberty blockers and cross-sex hormones, we were assured, were reserved for a tiny number of carefully assessed children with severe and persistent distress.
But when new data show that these treatments aren’t so rare, the same defenders suddenly change their tune: the numbers are no longer reassuring because they are small; now they are reassuring because they are large. More children receiving medical transition means that a previously hidden population finally feels safe enough to pursue the care it has always needed. Higher cross-sex identity persistence after social transition or administering puberty blockers means the interventions were obviously appropriate.
Continue reading the entire piece here at the Daily Wire
______________________
Colin Wright is a fellow at the Manhattan Institute. This piece is adapted from City Journal.